Page last updated: 2024-10-23

bisindolylmaleimide i and Anemia, Sickle Cell

bisindolylmaleimide i has been researched along with Anemia, Sickle Cell in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sultana, C1
Shen, Y1
Johnson, C1
Kalra, VK1

Other Studies

1 other study available for bisindolylmaleimide i and Anemia, Sickle Cell

ArticleYear
Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.
    Journal of cellular physiology, 1999, Volume: 179, Issue:1

    Topics: Adult; Anemia, Sickle Cell; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesi

1999